News
ALZN
0.7150
+0.82%
0.0058
Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying
When insiders purchase or sell shares, it indicates confidence or concern around the company's prospects. The Dow Jones index closed higher by over 250 points on Tuesday. Recent notable insider transactions for penny stocks include Conn’s, Inc. And Mobile Infrastructure Corporation. Conn's director bought a total of 10,000 shares at an average price of $3.71.
Benzinga · 1d ago
Weekly Report: what happened at ALZN last week (0415-0419)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Dynatronics (NASDAQ:DYNT) stock rose 84.9% to $0.69 during Tuesday's pre-market session. The company's market cap rose to $3.3 million. Inovio Pharmaceuticals shares fell 24.3% during the session. Akanda shares increased by 23.0% and BioRestorative Therapies shares moved upwards.
Benzinga · 04/16 12:07
Weekly Report: what happened at ALZN last week (0408-0412)?
Weekly Report · 04/15 10:32
Buy Rating Justified by Alzamend Neuro’s Promising Alzheimer’s Treatments and Attractive Valuation
TipRanks · 04/15 09:15
Weekly Report: what happened at ALZN last week (0401-0405)?
Weekly Report · 04/08 10:36
Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Recent notable insider transactions for penny stocks include Aldeyra Therapeutics, Inc. And Retractable Technologies.
Benzinga · 04/04 10:23
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Recent notable insider transactions for penny stocks include Alzamend Neuro and Gain Therapeutics. Silo Pharma, Inc. Also had a recent notable insider transaction.
Benzinga · 04/02 11:39
Weekly Report: what happened at ALZN last week (0325-0329)?
Weekly Report · 04/01 10:35
12 Health Care Stocks Moving In Wednesday's After-Market Session
Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The company's Q4 earnings report came out today. Fresh2 Group stock rose upwards by 5.26% as well.
Benzinga · 03/27 20:31
ALZN Stock Earnings: Alzamend Neuro Misses EPS for Q3 2024
Alzamend Neuro reported earnings per share of -38 cents for the third quarter of 2024. The company did not report any revenue for the quarter. This was below the analyst estimate for EPS of -32 cents. Alzamend neuro reported results for the fourth quarter of 2016.
Investorplace · 03/26 09:52
Alzamend Neuro Inc reports results for the quarter ended in January - Earnings Summary
Alzamend Neuro Inc reports results for the quarter ended in January. The company reported a quarterly adjusted loss of 38 cents per share. The mean expectation of two analysts was for the company to report a loss of 32 cents. Alzamend neuro Inc shares had risen by 20.2% this quarter.
Reuters · 03/25 22:32
Weekly Report: what happened at ALZN last week (0318-0322)?
Weekly Report · 03/25 10:37
Weekly Report: what happened at ALZN last week (0311-0315)?
Weekly Report · 03/18 10:36
Alzamend Neuro Inc <ALZN.OQ> expected to post a loss of 32 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 32 cents a share - Earnings Preview. The average analyst rating on the shares is "buy" for the period ending January 31 2024. The company is expected to show change in quarterly revenue when it reports results.
Reuters · 03/15 20:26
Alzamend Neuro Inc <ALZN.OQ> expected to post a loss of 32 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 32 cents a share - Earnings Preview. The company is expected to show change in quarterly revenue when it reports results on March 15. The mean analyst estimate for the company is for a quarterly loss of 32 cents per share.
Reuters · 03/13 20:02
Weekly Report: what happened at ALZN last week (0304-0308)?
Weekly Report · 03/11 10:34
Weekly Report: what happened at ALZN last week (0226-0301)?
Weekly Report · 03/04 10:36
Weekly Report: what happened at ALZN last week (0219-0223)?
Weekly Report · 02/26 10:45
Alzamend Neuro (ALZN) Price Target Increased by 25.00% to 25.50
NASDAQ · 02/24 16:06
More
Webull provides a variety of real-time ALZN stock news. You can receive the latest news about Alzamend Neuro Inc through multiple platforms. This information may help you make smarter investment decisions.
About ALZN
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's through a royalty-bearing exclusive worldwide license from the Licensor.